Abstract 2301: CA125 levels as a proxy for residual disease in a diverse cohort of epithelial ovarian cancer patients: results from the Kaiser Permanente Research on Ovarian Cancer Survival (KPROCS) study

Authors

Elisa V. Bandera (ORCID: https://orcid.org/0000-0002-8789-2755)
Lindsay Jane Collin (ORCID: https://orcid.org/0000-0003-0170-2592)
Lawrence H. Kushi (ORCID: https://orcid.org/0000-0001-9136-1175)
Farzin Khosrow‐Khavar (ORCID: https://orcid.org/0000-0003-3636-8918)
Juraj Kavecansky (ORCID: https://orcid.org/0000-0003-4389-6524)
Valerie S. Lee
Jennifer A. Doherty (ORCID: https://orcid.org/0000-0002-1454-8187)
Christine Ann Garcia (ORCID: https://orcid.org/0000-0002-0367-7813)
Scarlett Lin Gomez (ORCID: https://orcid.org/0000-0002-5143-4867)

Institutions

Rutgers, The State University of New Jersey (US)
Kaiser Permanente (US)
Emory University (US)
University of California, San Francisco (US)
Huntsman Cancer Institute (US)

Publication Details

Journal: Cancer Research
Published: 2025-04-21
DOI: https://doi.org/10.1158/1538-7445.am2025-2301
Primary Topic: Ovarian cancer diagnosis and treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Abstract 2301: CA125 levels as a proxy for residual disease in a diverse cohort of epithelial ovarian cancer patients: results from the Kaiser Permanente Research on Ovarian Cancer Survival (KPROCS) study

Elisa V. Bandera, Lindsay Jane Collin, Lawrence H. Kushi, Farzin Khosrow‐Khavar et al.

Apr 21, 2025

Cancer Research

Ovarian cancer diagnosis and treatment

article

Abstract 2301: CA125 levels as a proxy for residual disease in a diverse cohort of epithelial ovarian cancer patients: results from the Kaiser Permanente Research on Ovarian Cancer Survival (KPROCS) study

Elisa V. Bandera, Lindsay Jane Collin, Lawrence H. Kushi, Farzin Khosrow‐Khavar, Juraj Kavecansky, Valerie S. Lee, Jennifer A. Doherty, Christine Ann Garcia, Scarlett Lin Gomez

April 21, 2025article en

Abstract

No abstract available for this paper.

Cancer ResearchVol. 85(8_Supplement_1)

Rutgers, The State University of New Jersey (US), Kaiser Permanente (US), Emory University (US), University of California, San Francisco (US), Huntsman Cancer Institute (US)

Openalex Percentile: Top 88%

Ovarian cancer diagnosis and treatment

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Abstract 2301: CA125 levels as a proxy for residual disease in a diverse cohort of epithelial ovarian cancer patients: results from the Kaiser Permanente Research on Ovarian Cancer Survival (KPROCS) study — Elisa V. Bandera, Lindsay Jane Collin, et al. · Cancer Research (2025) | TGRS Research Map | TGRS